Amarin Reports Second Quarter 2025 Financial Results
Provided By GlobeNewswire
Last update: Jul 30, 2025
-- European Partnership with Recordati Established to Maximize VAZKEPA® in Europe; Global Corporate Restructuring Implemented with Anticipated $70 Million in Operating Expense Savings Over Next 12 Months --
Read more at globenewswire.comNASDAQ:AMRN (10/17/2025, 8:00:00 PM)
19.64
-0.43 (-2.14%)
Find more stocks in the Stock Screener
